Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
301258 Suzhou Fushilai Pharmaceutical
- 26.17
- +0.42+1.63%
Market Closed Dec 20 15:00 CST
2.40BMarket Cap127.04P/E (TTM)
26.38High25.71Low12.17KlotVolume25.74Open25.75Pre Close31.76MTurnover3.59%Turnover Ratio21.38P/E (Static)91.67MShares42.7952wk High1.27P/B885.74MFloat Cap19.0652wk Low30.90Limit Up33.85MShs Float78.81Historical High20.60Limit Down2.60%Amplitude19.06Historical Low0.60Dividend TTM26.10Avg Price5.46KlotAsk2.30%Div YieldTTM100Lot Size6.07KlotBid
Suzhou Fushilai Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -19.59%312.49M | -27.14%216.64M | -38.47%96.29M | -13.89%489.29M | -2.35%388.63M | 9.17%297.35M | 10.38%156.49M | 8.92%568.21M | 12.86%397.98M | 5.79%272.36M |
| Operating revenue | -19.59%312.49M | -27.14%216.64M | -38.47%96.29M | -13.89%489.29M | -2.35%388.63M | 9.17%297.35M | 10.38%156.49M | 8.92%568.21M | 12.86%397.98M | 5.79%272.36M |
| Other operating revenue | ---- | -71.11%1.41M | ---- | -67.86%6.19M | ---- | -63.02%4.89M | ---- | 92.00%19.26M | ---- | 148.29%13.23M |
| Total operating cost | 8.71%313.8M | 4.10%210.46M | -11.56%93.17M | 5.89%389.09M | 12.02%288.66M | 14.84%202.17M | 2.67%105.35M | -4.75%367.44M | 0.24%257.68M | -4.65%176.04M |
| Operating cost | 10.65%248.44M | 4.28%168.43M | -11.93%73.94M | -3.15%301.38M | 0.84%224.54M | 8.46%161.52M | 4.21%83.95M | -0.11%311.18M | 7.98%222.66M | -0.64%148.92M |
| Operating tax surcharges | -36.14%2.91M | -36.66%2.14M | -44.37%933.72K | 6.13%5.41M | 24.12%4.55M | 17.38%3.38M | 8.18%1.68M | 24.12%5.1M | 17.56%3.67M | 45.87%2.88M |
| Operating expense | 3.72%3.83M | 18.99%2.75M | -6.86%1.07M | 10.10%4.89M | 9.98%3.69M | 12.27%2.31M | -2.55%1.15M | -5.47%4.44M | -7.62%3.35M | -14.57%2.06M |
| Administration expense | -7.61%30.76M | -9.06%20.61M | -12.19%8.82M | 6.46%46M | 5.37%33.29M | 5.31%22.66M | 3.27%10.05M | 31.98%43.2M | 32.48%31.59M | 45.77%21.52M |
| Financial expense | 42.98%-4.54M | 6.41%-6.43M | -315.57%-2.9M | 75.45%-9.29M | 77.13%-7.96M | 65.12%-6.88M | -184.23%-698.55K | -1,007.46%-37.86M | -31,508.21%-34.79M | -1,658.72%-19.71M |
| -Interest expense (Financial expense) | -21.24%70.64K | -20.59%48.72K | -19.97%25.17K | -62.09%116.46K | -64.30%89.69K | -75.58%61.35K | -82.27%31.45K | -31.74%307.22K | -6.51%251.21K | 187.51%251.21K |
| -Interest Income (Financial expense) | 9.01%-5.15M | -12.84%-4.35M | -41.31%-2.33M | -20.15%-8.11M | -31.99%-5.66M | -22.10%-3.85M | -141.59%-1.65M | -239.36%-6.75M | -259.75%-4.29M | -341.18%-3.16M |
| Research and development | 6.09%32.41M | 19.82%22.97M | 22.63%11.31M | -1.61%40.7M | -2.08%30.55M | -5.90%19.17M | 5.18%9.23M | 45.08%41.37M | 53.24%31.19M | 41.97%20.37M |
| Credit Impairment Loss | -167.10%-797.52K | -317.04%-1.1M | -115.41%-127.51K | 441.99%1.17M | 51.08%1.19M | 101.34%508.37K | 248.89%827.37K | 15.90%-342.52K | -23.78%786.75K | 89.69%252.49K |
| Asset Impairment Loss | -775.28%-14.46M | -726.21%-13.5M | -36.76%-274.76K | 104.31%160.29K | 1.96%2.14M | 14.60%2.16M | ---200.9K | -36.15%-3.72M | 542.12%2.1M | 12,586.91%1.88M |
| Other net revenue | -30.21%18.2M | -142.00%-7.21M | -65.45%3.14M | 577.39%33.42M | 223.62%26.07M | 112.54%17.16M | 23.55%9.08M | -12.99%4.93M | 24.02%8.06M | 139.20%8.07M |
| Fair value change income | 95.77%11.15M | -627.04%-5.32M | -300.50%-5.17M | 833.09%6.31M | 143.80%5.7M | 115.45%1.01M | 330.10%2.58M | -153.35%-860.99K | -1,900.15%-13M | -45,392.83%-6.54M |
| Invest income | 29.63%18.29M | -15.30%9.94M | 48.16%7.27M | 1,332.26%20.86M | 44.35%14.11M | 111.30%11.73M | 313.20%4.91M | -44.65%1.46M | 484.48%9.77M | 255.07%5.55M |
| Asset deal income | ---101.86K | ---- | ---- | ---392.26K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other revenue | 39.96%4.11M | 58.26%2.78M | 47.36%1.44M | -36.77%5.31M | -65.00%2.94M | -74.65%1.76M | -84.08%974.56K | 84.02%8.4M | 136.95%8.4M | 312.44%6.93M |
| Operating profit | -86.61%16.88M | -100.92%-1.03M | -89.61%6.26M | -35.04%133.62M | -15.04%126.04M | 7.60%112.34M | 29.48%60.23M | 45.25%205.71M | 45.32%148.36M | 36.99%104.4M |
| Add:Non operating Income | 122.74%4.38K | 354.90%3.46K | 329.63%2.32K | 4.29%47.4K | 80.29%1.97K | 55.12%760.11 | 38.46%540 | 2,033.81%45.45K | -36.99%1.09K | 58.06%490 |
| Less:Non operating expense | -22.68%1.71M | 12.38%779.77K | -37.01%280.06K | 55.51%5.12M | 19.16%2.21M | 5.02%693.87K | 142.29%444.6K | 3.56%3.3M | -32.75%1.85M | -67.68%660.72K |
| Total profit | -87.74%15.18M | -101.62%-1.81M | -90.00%5.98M | -36.51%128.54M | -15.48%123.83M | 7.62%111.65M | 29.03%59.79M | 46.24%202.46M | 47.48%146.51M | 39.87%103.74M |
| Less:Income tax cost | -92.01%1.33M | -109.54%-1.46M | -97.64%192.68K | -34.95%16.36M | -13.88%16.68M | 11.38%15.3M | 27.50%8.18M | 37.89%25.15M | 47.23%19.37M | 22.81%13.74M |
| Net profit | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M | 29.28%51.61M | 47.51%177.31M | 47.52%127.13M | 42.90%90M |
| Net profit from continuing operation | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M | 29.28%51.61M | 47.51%177.31M | 47.52%127.13M | 42.90%90M |
| Net profit of parent company owners | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M | 29.28%51.61M | 47.51%177.31M | 47.52%127.13M | 42.90%90M |
| Earning per share | ||||||||||
| Basic earning per share | -87.08%0.151 | -100.36%-0.0038 | -88.79%0.0631 | -40.78%1.22 | -22.74%1.1689 | -6.34%1.051 | -2.93%0.563 | 17.71%2.06 | 20.70%1.513 | 22.49%1.1221 |
| Diluted earning per share | -87.08%0.151 | -100.36%-0.0038 | -88.79%0.0631 | -40.78%1.22 | -22.74%1.1689 | -6.34%1.051 | -2.93%0.563 | 17.71%2.06 | 20.70%1.513 | 22.49%1.1221 |
| Other composite income | ||||||||||
| Total composite income | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M | 29.28%51.61M | 47.51%177.31M | 47.52%127.13M | 42.90%90M |
| Total composite income of parent company owners | -87.08%13.84M | -100.36%-349.34K | -88.79%5.79M | -36.73%112.18M | -15.72%107.15M | 7.05%96.34M | 29.28%51.61M | 47.51%177.31M | 47.52%127.13M | 42.90%90M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
